Hypertension (high blood pressure) Board decisions

The Board denied the Veteran's claims for service connection for obstructive sleep apnea and hypertension, finding that these conditions were not incurred in or caused by active service and did not result from a service-connected disability.

The Board remands the claims for service connection for a bilateral lung disability, hypertension, and migraine headaches due to insufficient evidence regarding their relationship to in-service toxic exposures.

The Board denied service connection for hypertension and headaches as the evidence did not support a finding that these conditions were incurred in or aggravated by active military service.

The Veteran's service-connected disabilities, including depression associated with tinnitus, left knee strain, tinnitus, hypertension, and hearing loss, render him unable to secure and follow a substantially gainful occupation consistent with his education and occupational experience.

The Board remands the claim for service connection of the Veteran's cause of death to correct a pre-decisional duty to assist error.

The Veteran's irritable bowel syndrome (IBS) is granted a 30 percent disability rating, but no higher. The claims for increased ratings and service connection for other conditions are denied.

The Board denied the Veteran's appeal for an initial compensable rating for hypertension, as there was no evidence of diastolic pressure predominantly 100 or more, or systolic pressure predominantly 160 or more.

The Board vacates its August 7, 2025 decision and remands the issue of service connection for hypertension due to PTSD for further development.

The Board granted service connection for diabetes mellitus, type II, left and right lower extremity peripheral neuropathy, and hypertension, all presumed to be due to herbicide exposure during the Veteran's service in Korea.

The Board denied service connection for meniscal tear, osteoarthritis, and chondrocalcinosis of the right knee and hypertension. The claims for TBI, chronic upset stomach, and prostate cancer were remanded.

The Board granted an initial 10 percent rating for the Veteran's service-connected hypertension, as it required continuous medication for control during the appeal period.

The Board granted service connection for the cause of the Veteran's death, finding that his presumptively service-connected hypertension materially contributed to his cardiac arrest, severe metabolic acidosis, and statis epilepticus-intractable seizures.

The Board remands the claims for service connection and increased ratings due to a pre-decisional duty-to-assist error in scheduling examinations.

The Veteran was granted a 100 percent rating for ascending aortic aneurysm from January 26, 2024, to July 11, 2024, and a 10 percent rating for hypertension. The appeal for TDIU and service connection for atrial fibrillation was remanded.

The Board granted a 10 percent disability rating for hypertension, finding that the Veteran's diastolic blood pressure was predominantly 100 or more in the past.

The Board denied the veteran's claims for increased ratings for major depressive disorder with anxious distress and insomnia, painful right hand laceration scar, right hand laceration scar associated with underlying soft tissue damage, and hypertension.

The Board granted an effective date of September 9, 2016 for the grant of service connection for diabetes and hypertension based on presumptive exposure to herbicide agents while stationed at U-Tapao RTAFB.

The Board remands the claims for service connection for a respiratory condition, hypertension, and temporomandibular disorder to correct a duty to assist error that occurred prior to the issuance of the November 2024 rating decision.

The Board denied the Veteran's claim for service connection for hypertension, finding that there was no evidence of a causal relationship between the claimed in-service disease or injury and the current disability.

The Board granted service connection for hypertension, resolving reasonable doubt in the Veteran's favor based on evidence of in-service toxic activity risk exposure (TERA) and medical literature supporting a link between such exposure and hypertension.